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Abstract
Prolactin (PRL) exerts pleiotropic physiological effects in various cells and tissues, and is mainly
considered as a regulator of reproduction and cell growth. Null mutation of the PRL receptor (R)
gene leads to female sterility due to a complete failure of embryo implantation. Pre-implantatory
egg development, implantation and decidualization in the mouse appear to be dependent on ovarian
rather than uterine PRLR expression, since progesterone replacement permits the rescue of
normal implantation and early pregnancy. To better understand PRL receptor deficiency, we
analyzed in detail ovarian and corpora lutea development of PRLR-/- females. The present study
demonstrates that the ovulation rate is not different between PRLR+/+ and PRLR-/- mice. The
corpus luteum is formed but an elevated level of apoptosis and extensive inhibition of angiogenesis
occur during the luteal transition in the absence of prolactin signaling. These modifications lead to
the decrease of LH receptor expression and consequently to a loss of the enzymatic cascades
necessary to produce adequate levels of progesterone which are required for the maintenance of
pregnancy.
Background
Prolactin (PRL) is a multifunctional hormone involved in
diverse processes such as luteal function and thus mainte-
nance of the pregnancy [1], and has long been known for
its luteotropic actions in rodents [2–5]. Hormonal re-
sponsiveness in the mammalian ovary involves complex
cellular processes that are essential for organ function and
which can be deleterious if inappropriately orchestrated.
After ovulation, subsequent luteinization leads to the for-
mation of the corpus luteum, which is an endocrine gland
of limited lifespan. This resulting corpus luteum is a high-
ly vascularized endocrine organ producing progesterone,
essential for uterine preparation and maintenance of preg-
nancy. The granulosa cells remaining in the postovulatory
follicle undergo luteinization, which involves exit of the
cells from the cell cycle, cellular hypertrophy, acquisition
of steroidogenic morphology, and expression of cyto-
chrome P450 cholesterol side chain cleavage.
We previously demonstrated that female mice ho-
mozygous for a disruption of PRL receptor (PRLR) gene
are infertile due to a failure of implantation [6]. PRL me-
diates its action via a single receptor, which is present in
the corpus luteum during pregnancy and is also expressed
in the uterus later in the pregnancy [7]. The PRL receptor
is thus a key component regulating ovarian function and
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governing the regulation of progesterone secretion and, in
fact PRL may trigger an early signal to induce the mainte-
nance of the corpus luteum.
In rodents, semi-circadian surges of PRL secretion are in-
duced by cervical stimuli, which are believed to be respon-
sible for the conversion of the corpus luteum of pregnancy
(CLP) from the corpus luteum (CL) of the cycle. The CLP
secretes a sufficient progesterone amount to maintain
pregnancy [8,9].
The factors affecting sterility of PRLR-/- mice were attrib-
uted to multiple causes, in particular to the absence of suf-
ficient progesterone to support implantation and
subsequent placental development and maintenance [6].
Since the corpus luteum is the unique source of progester-
one production in rodents, progesterone administration
is able to rescue preimplantation egg development and
embryo implantation in PRLR-/- female [10].
To better understand PRL receptor deficiency, we analyzed
in detail follicular development, the ovulation process
and the subsequent expression of specific mRNAs of en-
zymes involved in steroid production using RT-PCR and
in situ hybridization, in a time-dependent manner, during
the first stages of early pregnancy of PRLR-/- females. The
present study provides new evidence to support the im-
portance of prolactin for survival of the luteal cells in preg-
nant mice.
Materials and Methods
Experimental animals
Wild type and PRLR-/- female mice (129/Sv) were gener-
ated by intercrosses of heterozygous mice (PRLR+/-). Off-
spring were genotyped by PCR analysis as described
previously [10]. The morning of finding a vaginal plug
was designated day 0.5 of pregnancy. Animals were
housed in a 12-hour day/night cycle at 22°C and relative
humidity 50% with food and water ad libitum. Experi-
mental designs and procedures are in agreement with the
guidelines of the animal ethics committee of the Ministère
de l'Agriculture.
Analysis of estrous cycle
Vaginal smears from 12 PRLR+/+ and 15 PRLR-/- 11-
week-old females were collected every day for a 21-day pe-
riod. Smears were streaked on slides and estrous cycle
stages were determined.
Egg collection and tissue preparation
Eggs were recovered from the oviduct or uterus of the mice
as previously described [6]. Wild type and PRLR-/- ovaries
were collected on days 0.5, 1.5, 2.5 and 3.5 after observa-
tion of a vaginal plug, pregnancy was confirmed by recov-
ery of eggs from the ampulla, the oviducts or from the
uterine lumen. Ovaries were removed and fixed in Bouin's
fixative, embedded in paraffin and serially sectioned at 5
µm, sections were stained with hematoxylin-eosin-safran.
Ovarian tissues were fixed in 10% paraformaldehyde to
perform immunohistochemistry of frozen sections.
Hormone treatment
To examine the response to gonadotropins and induction
of sexual receptivity, female mice aged 4 weeks, were in-
jected i.p. with 5 UI of Folligon® (PMSg: Pregnant Mare's
Serum gonadotropin, Intervet Inc., Millsboro, DE) to
stimulate follicular growth. They were injected 48 h later
with 5 UI of Chorulon® (hCG: human Chorionic Gonado-
tropin, Intervet, Millsboro, DE) to trigger ovulation and
luteinization. After ovulation, oocytes were collected from
the ampulla and counted after enzymatic dissociation
from the surrounding cumulus with hyaluronidase (Sig-
ma; 100 µl type IV-S; 10 mg/ml). The mean number of
oocytes recovered following super-ovulation was calculat-
ed using ovaries from 10 PRLR-/- and 12 PRLR+/+.
Immunohistochemical localization of Platelet Endothelial 
Cell Adhesion Molecule-1 (PECAM-1)
Wild type and PRLR-/- ovaries were collected on days 1.5–
3.5 of pregnancy and flash frozen for detection of the en-
dothelial immunofluorescence staining. After fixation of
frozen sections with acetone, positive sites of rehydrated
sections were neutralized by 0.75% glycine. Sections were
blocked for 10 min in 5% fetal sheep serum (Gibco BRL®),
then incubated with a 10 µg/ml concentration of the R-
Phycoerythrin-conjugated rat anti-mouse PECAM-1 mon-
oclonal antibody (BD Biosciences) for 1 h. Cells observed
by confocal microscopy (Zeiss) exhibiting fluorescence
were considered positive for endothelial cell detection.
Negative controls, conducted with a non immune labeled
rat IgG, yielded no reaction product.
Terminal deoxynucleotidyl transferase-mediated dUTP 
nick end labeling (Tunel)
The occurrence of apoptosis in paraffin-embedded sec-
tions from PMSG/hCG stimulated ovaries sections was as-
sessed by monitoring the presence of in situ DNA
fragmentation using the In Situ Cell death Detection kit,
Fluorescein (Roche Diagnostics Corporation, IN) follow-
ing the manufacturer's instructions. At least four mice of
each genotype were analyzed.
Analysis involved confocal microscopy (Zeiss) to identify
fluorescently-labeled cells which were considered positive
for DNA fragmentation.
Semiquantitative RT-PCR analysis
Total RNA was extracted from super-ovulated ovaries by
modified guanidine isothiocyanate phenol chloroform
(Trizol), 1 µg was reverse transcribed using 1 µg oligo-dTReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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(Amersham Pharmacia Biotech), 200 U of M-MLV reverse
transcriptase (Gibco BRL®), 1 mM of dNTP and 40 U of
RNAsine (Gibco BRL®) for 30 min at 37 C. The amplifica-
tion of transcripts was performed with specific primers
listed below (5 mM each) using Taq polymerase (Gibco
BRL®) on 1 µl of the RT reaction in a mix containing 0.5
mM of dNTP, 2.5 mM of MgCl2 (except for IGFBP3: 1.5
mM), in 20 µl final. PCR was carried out for 15, 20, 23, or
30 cycles to insure the linear amplification, with an an-
nealing temperature of 61 C, except for 3β-HSD where a
60 C annealing temperature was used. The experimental
conditions were such that the amplification was exponen-
tial. Products were resolved by electrophoresis on 1% aga-
rose gel, which was stained with ethidium bromide. Data
were analyzed with EDAS-120 system (Kodak digital im-
aging system) and software. The intensity of signals was
standardized by the use of GAPDH, which was included
in each experiment as an internal control. The mouse oli-
gonucleotides primers (Eurogentec) used were as follows:
Cytochrome P450 side-chain cleavage (P450scc), 5'
GCCAACATTACCGAGATG C 3' and 5' ACAC-
CCCAGCCAAAGCC 3', Steroidogenic acute regulatory
protein (StAR), 5' TCGCTTGGAGGTGGTGGTAGAC
3'and 5' GCAGGTCAATGTGGTGGACAGT 3', Luteinizing
Hormone Receptor (LHR), 5' CTTATACATAACCACCAT-
ACCAG 3'and 5' ATCCCAGCCACTGAGTTCATTC 3', In-
sulin Growth Factor Binding Protein-3 (IGFBP-3), 5'
CGCGAAGGCGACGCGTGC 3' and 5' CATTGAGGAACT-
TCAGATGATTC 3', 3βhydroxysteroid deshydrogenase
(3β-HSD), 5' GGTATTCTGAGAAGTTTTGGC 3' and 5'
GGCAGCAGCACCTGTCTTG 3', 20α hydroxysteroid
deshydrogenase (20α-HSD): 5' GCAGGATT-
GGCCAAGTCCATC 3' and 5' GTACCGAAGATTTCTGTC-
CAG 3'and glyceraldehyde-phosphate dehydrogenase
(GAPDH) 5' GAGGGATCTCGCTCCTGGAAGA 3'and
5'GGTGAAGGTCGGAGTCAACGGA 3'. Predicted prod-
ucts were 426, 522, 516, 471, 577, 440 and 230 bp
respectively.
Western blot analysis
Protein extraction was performed in ice-cold homogeni-
zation buffer containing 40 mM Tris-HCl (pH 8), 276 mM
NaCl, 20% glycerol, 2% Nonidet P-40 (Interchim), 4 mM
EDTA, 1 mM phenylmethylsulfonyl fluoride (Sigma), 5
µg/ml aprotinin (Sigma), 2 µg/ml leupeptin (Sigma), and
1 µM pepstatin(Sigma), with a Polytron homogenizer.
The total homogenates were centrifuged at 10, 000 rpm at
4°C for 15 min. Fifty micrograms of soluble protein were
run on 10% SDS-PAGE gels and electrotransferred to ni-
trocellulose membranes (Amersham). The membranes
were blocked with 5% nonfat dried milk in 50 mM Tris-
buffered saline (TBS) containing 0.1% Tween-20 (Sigma)
followed by incubation overnight with the recommended
dilution of primary antibody. Antibodies used were poly-
clonal anti-p27 (SC-528, Santa Cruz Biotechnology Inc,
Santa Cruz, CA), (1:200 dilution), monoclonal anti-cyclin
D2 (SC-593, Santa Cruz Biotechnology Inc, Santa Cruz,
CA) or polyclonal anti-P450scc at 1:1000 dilution kindly
provided by Dr. P. Monget. The membranes were then
washed extensively in TBS containing 0.5% Tween-20
(TBS-T) and incubated with 1:500 dilution of antimouse
(or antirabbit IgG) peroxidase-linked antibody (Amer-
sham Pharmacia Biotech) in 5% milk for 90 min at room
temperature. After washing in TBS-T, blots were devel-
oped using an enhanced chemiluminescence Western
blotting detection system (Amersham Pharmacia Biotech)
and exposed to X-ray films (Konica).
In situ hybridization
Ovaries were fresh frozen and serially sectioned (8 µm)
using a Zeiss cryostat. Sections were mounted onto posi-
tively charged glass slides, fixed in 4% paraformaldehyde
(pH 7.4) for 10 min at room temperature, washed in 2 ×
PBS for 5 min, incubated in 0.2 % acetic anhydride in 0.1
M thiethanolamine (pH 8.0) for 10 min and rinsed in 2 ×
saline sodium citrate (SSC) 2 × 2 min as described in [11].
[35S]-UTP-labeled sense and anti-sense probes were syn-
thesized using SP6 or T7 RNA polymerase (Promega Corp,
Madison, WI). Sections were coated with the labeled
probe and then incubated overnight at 45 C. After hybrid-
ization, the slides were washed at high stringency and
treated with ribonuclease A (20 µg/ml) at 37 C for 20 min,
washed for 30 min at 60 C in 1 × SSC and dehydrated
through an ethanol series. After drying, the slides were
dipped in photographic NTB-2 emulsion (Eastman Ko-
dak) and exposed at 4 C for 5–15 days. Slides were devel-
oped with Kodak D-19 developer and fixer (Eastman
Kodak) then stained with hematoxylin. Bright field pho-
tography shows the tissue histology while dark field illu-
mination allows visualization of the mRNA.
Statistical analysis
The experimental data were analyzed by Student's test, or
one-way ANOVA. Appropriate pairwise comparisons be-
tween pairs of animals were carried out. Each RT-PCR ex-
periment was independently replicated at least three times
with three different mice each day of gestation. All values
are expressed as means ± SEM of combined data from the
replicate experiments. For quantitative analysis, ANOVA
followed by Student's t-test was used. Values of p < 0.05
(*) were considered statistically significant.
Results
Estrous cycle and ovulation rate in PRLR-/- mice
Preliminary observations indicated irregular estrous cycles
in PRLR-/- females [6]. These observations were re-evalu-
ated in light of the availability of animals on a pure 129Sv
genetic background. Each stage of the estrous cycle was
confirmed by the cytological analysis of vaginal smears. A
rhythmic periodicity with a recognizable estrus wasReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
Page 4 of 16
(page number not for citation purposes)
evident in both genotypes and the length of estrous cycle
was not statistically different between PRLR-/- mice (4.7 ±
0.3 days) and wild type mice (5.1 ± 0.3 days).
The number of oocytes 10 to 12 h after ovulation from
PRLR-/- females as well as the number of corresponding
corpora lutea on ovarian sections, was statistically not dif-
ferent in the two groups: PRLR-/- oocytes number 9.3 ±
0.4 (n = 14) and +/+ control 8.7 ± 0.2 mice (n = 15), sug-
gesting that ovulation rate was not altered in PRLR-/-
mice.
To test the ovarian responsiveness to supra-physiological
levels of exogenous gonadotropins, mice were superovu-
lated. Recovered oocytes were 31.6 ± 4.8 (n = 10) in PRLR-
/- versus 37.5 ± 5.5 (n = 12) in wild type mice. These re-
sults show no statistically significant differences indicat-
ing that PRL receptor deficiency does not modify the
ovarian responsiveness to gonadotropins.
Figure 1
Histological analysis of ovary from wild-type and PRLR-/- mice. Representative view of sections of ovaries from PRLR+/+ (A 
and C) and PRLR-/- (B and D) from 8-week-old female mice were stained with Hematoxylin-eosin. Both ovaries contain all 
developmental stages of follicles (A and B), scale bar: 1 mm. Details of corpus luteum are shown in panel C and D, scale bar: 
100 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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Figure 2
Detection of apoptosis in control +/+ and PRLR-/- corpora lutea by the Tunel method. Apoptotic nuclei are labeled green by 
Tunel with fluorescein detection. Corpora lutea in wild-type (A, C, E) and PRLR-/- (B, D, F) ovaries are shown at D0.5 (A, B); 
D1.5 (C, D) and D2.5 (E, F) after fertilization. Analysis of sections by confocal microscopy exhibits fluorescence only in PRLR-/
- ovaries at days 1.5 and 2.5 (shown by arrows) of pregnancy where several apoptotic nuclei are present in PRLR-/- (D, F) com-
pared to wild type follicles (C, E). Scale bar is 100 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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Ovarian histology
After morphometric analysis of ovaries, no difference was
seen between wild-type and PRLR-/- mice in terms of
weight and size, with all stages of follicular development
being represented, including mature Graafian follicles
(Figure 1A and 1B), as well as corpora lutea (CL), indicat-
ing previous spontaneous ovulation. Although CL were
observed in the ovaries of both +/+ and -/- females, their
morphology was different. Whereas ovaries from wild-
type mice had large corpora lutea with classical morphol-
ogy (Figure 1C), -/- mice exhibited corpora lutea undergo-
ing regression, where cells are highly disorganized (Figure
1D). These data indicate that a major cause of infertility is
the lack of formation of the CLP, which provokes proges-
terone insufficiency.
Apoptotic cells: Tunel
Sections from the ovaries of PRLR-/- females taken from
day 0.5 to day 3.5 after mating displayed apparently re-
gressed CL. One of the first morphological signs of apop-
tosis is the appearance of nuclear fragments containing
degenerate chromatin. A Tunel assay was performed on
sections of stimulated ovaries enriched into corpora lutea
number (Figure 2). Fluorescein staining, detecting DNA
cleavage associated with apoptosis, was strongly and ex-
clusively expressed in the PRLR-/- corpora lutea (Figure
2B,2D and 2F) from day 1.5 (Figure 2D) with extensive la-
beling on day 2.5 (Figure 2F) declining by day 3.5 (not
shown). No staining was detected in wild type corpora
lutea on the first four days of pregnancy (Figure 2A,2C
and 2E).
Following ovulation, luteinization involves a number of
changes in the steroidogenic cells as well as in the vascu-
larization of the gland. The granulosa cell differentiation
to luteal cells is accompanied with angiogenesis and im-
portant vascular modifications. PECAM-1/CD31 mediat-
ed endothelial cell-cell interactions are involved in
angiogenesis. To follow the endothelial cells proliferation
ovarian sections were assessed with CD31 (Figure 3). At
day 2.5 of pregnancy the PRLR+/+ CL (Figure 3A) showed
high PECAM/CD31 activity whereas the PRLR-/- CL (Fig-
ure 3B) was extremely low indicating little
vascularization.
Figure 3
Immunohistochemistry staining for PECAM-1 in PRLR+/+ (A) and -/-(B) corpus luteum. Microvessels supplying the CL did stain 
for PECAM-1 in wild-type whereas staining is very reduced in PRLR-/- CL (B). Scale bar, 100 µm.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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Markers of ovulatory competence and steroidogenic 
enzymes
Granulosa cells remaining in the postovulatory follicle
undergo luteinization, which involves exit of the cells
from the cell cycle, cellular hypertrophy and acquisition
of steroidogenic enzymes. PRL is known to affect a
number of genes whose expression is essential for func-
tional corpus luteum, such as luteinizing hormone recep-
tor (LHR). LHR is an important stimulator of luteal
steroidogenesis and acutely upregulates progesterone pro-
duction through the stimulation of steroidogenic en-
zymes [12].
In order to study the effects of the lack of PRL signaling on
LHR mRNA expression levels, we analyzed the ovarian ex-
pression of LHR during the first four days of pregnancy by
semi-quantitative RT-PCR analysis and in situ hybridiza-
tion (Figure 4). The level of LHR mRNA was significantly
reduced in PRLR-/- versus wild type females from day 1.5
to day 3.5 of pregnancy (Figure 4A). At this time LHR
mRNA content in PRLR-/- ovaries is at least 2-fold less
than the quantity detected in the wild-type ovaries. In situ
hybridization experiments indicate that LHR is expressed
strongly in corpora lutea, preovulatory granulosa cells
and, to a lesser extent, theca and interstitial cells in wild
type ovaries, while on day 2.5 the labeling is weak or un-
detectable in corpora lutea of -/- mice (Figure 4B right). It
is well established that LH-induced increases in intracellu-
lar cAMP, leading to subsequent stimulation of StAR
mRNA (Steroidogenic Acute Regulatory protein) synthesis
and StAR protein phosphorylation and stimulation of
progesterone synthesis in vitro [13]. StAR is known to per-
mit the import of cholesterol to mitochondria. Expression
of StAR mRNA (Figure 5A) was significantly reduced in
PRLR-/- females from day 2.5 to day 3.5 as compared to
PRLR+/+ ovaries. The presence of StAR in CL was con-
firmed by in situ hybridization in PRLR+/+ ovaries (Figure
5B left panel), whereas no mRNA StAR expression was de-
tected in PRLR-/- mice (Figure 5B right panel).
LH is known to acutely upregulate progesterone produc-
tion through the stimulation of cholesterol transport to
P450 side chain cleavage (P450scc) on the inner mito-
chondrial membrane, this enzyme is a marker of differen-
tiated luteal cells [14]. Steroidogenic enzymes implicated
in the conversion of cholesterol to pregnenolone and pro-
gesterone were assessed using semi-quantitative RT-PCR
and in situ hybrization. P450scc mRNA (Figure 6A) was
significantly reduced in PRLR-/- females from day 2.5
when compared to wild-type females, whereas the expres-
sion of 3β-HSD mRNA was decreased significantly earlier
(Figure 7A). While P450scc mRNAs are expressed abun-
dantly in PRLR+/+ corpora lutea (Figure 6C, left panel), in
situ hybridization showed a progressive loss then an ab-
sence at day 2.5 in PRLR-/- ovaries (Figure 6C right panel).
Using Western blotting, the amount of P450scc protein
was altered from day 1.5 and decreased at day 2.5 in
PRLR-/- mice (Figure 6B).
Functional corpora lutea synthesize progesterone, while
corpora lutea undergoing regression express the 20α-HSD
enzyme, which converts progesterone to a metabolite
without progestational activity [15]. As suppression of
20α-HSD expression has been proposed to be due to pro-
lactin, we tested the expression of the 20α-HSD mRNA,
and found it to be increased in PRLR-/- females (Figure
7B) demonstrating the absence of an inhibitory effect of
PRL in -/- mice. Another marker of CL is IGFBP-3 (Insulin
like Growth factor Binding Protein-3) since in the ovary it
is known to be expressed exclusively in cells of the corpus
luteum [16]. Transcripts were expressed at the beginning
of pregnancy in wild type mice and increased until day 2.5
(Figure 8), but after day 1.5 expression in PRLR-/- females
was significantly less than in +/+ mice.
Luteal transition
Cyclin D2 and p27 have been shown to be required for
ovarian function by gene disruption studies [17,18] The
granulosa cells exit the cell cycle and terminally differenti-
ate, the molecular evidence for this halt in cell prolifera-
tion being the loss of expression of cyclin D2 and the
increased expression of p21 and p27 [19]. To assess the re-
lationship of theses genes products to the PRLR, we exam-
ined expression of these key proteins implicated in the
granulosa G1-S phase transition in ovaries of both geno-
types (Figure 9).
Cyclin D2 protein was down-regulated in PRLR+/+ ova-
ries as granulosa cells differentiated to luteal cells; these
cells acquired cell cycle inhibitor p27 on day 1.5 of preg-
nancy. In contrast, PRLR-/- ovaries cells expressed very
low levels of cyclin D2. Although initially decreased by
LH, p27 did not reach high levels during the course of
luteinization which was curtailed in this model. We also
examined the expression of p21 in wild-type ovaries. It
paralleled those of p27 but was not detectable in PRLR-/-
ovaries (not shown). Therefore, ovulation induced rapid
changes in the expression of p21, as well as cyclin D2 and
p27, during the terminal differentiation of granulosa cells
to luteal cells. This transition was greatly compromised in
-/- ovaries.
Discussion
PRL has been shown to have a dual role in luteal function
in the rat, with many studies demonstrating that PRL has
a luteotrophic action [20] but that it can also induce lute-
olysis [12,21]. During pregnancy PRL and placental lac-
togens bind to the PRLR, and thus PRLR deficiency
appears to be the best model to study the crucial action ofReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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Figure 4
Expression of LH receptor mRNA. A. Semi quantitative RT-PCR analysis (using GAPDH as an internal control) of LHR mRNA 
in +/+ (black bars) and -/- (hatched bars) ovaries at 0.5, 1.5, 2.5 and 3.5 day post coitum (d.p.c.); upper panel, inverse picture of 
ethidium bromide stained agarose gel shows a typical RT-PCR reaction; lower panel, bars, means ± SEM of the densitometric 
analysis (n = 6 for each stage). B. In situ hybridization of LHR in ovarian sections at 2.5 d.p.c. of PRLR+/+ and PRLR-/- mice. The 
predominant source of LHR expression is within cells of corpora lutea. A representative section is shown at low-power magni-
fication in bright field (above) and dark field (below) to demonstrate the histology and highlight the hybridization signal, respec-
tively. In the absence of the PRLR, expression of LHR (arrows) is no longer seen in corpora lutea but is seen in the theca cells 
and in the interstitial cell population. Negative control sections probed with sense riboprobes showed no defined pattern of 
probe hybridization (data not shown).Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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Figure 5
Expression of StAR mRNA. A. Semi quantitative RT-PCR analysis (using GAPDH as an internal control) of StAR mRNA in +/+ 
(black bars) and -/- (hatched bars) ovaries at 0.5, 1.5, 2.5 and 3.5 day post coitum (d.p.c.). upper panel, inverse picture of ethid-
ium bromide stained agarose gel shows a typical RT-PCR reaction; lower panel, bars, means ± SEM of the densitometric analysis. 
B. In situ hybridization of StAR in ovarian sections at 2.5 d.p.c. of PRLR+/+ and PRLR-/- mice. The predominant source of StAR 
expression is within cells of corpora lutea. A representative section is shown.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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Figure 6
Expression of P450scc. A. Semi quantitative RT-PCR analysis of P450scc mRNA in +/+ (black bars) and -/- (hatched bars) ova-
ries at 0.5, 1.5, 2.5 and 3.5 day post coitum (d.p.c.). upper panel, inverse picture of ethidium bromide stained agarose gel shows 
a typical RT-PCR reaction; lower panel, bars, means ± SEM of the densitometric analysis. B. Western blot analysis of P450scc 
protein, equal amounts of total proteins were resolved on 10% SDS-PAGE gels and transferred to nitrocellulose membrane 
then probed with polyclonal antibody at D1.5 and 2.5. C. In situ hybridization of P450scc in ovarian sections at 2.5 d.p.c. of 
PRLR+/+ and PRLR-/- mice.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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Figure 7
Expression of 3β-HSD and 20α-HSDc. A. Semi quantitative RT-PCR analysis of 3β-HSD mRNA in +/+ (black bars) and -/- 
(hatched bars) ovaries at 0.5, 1.5, 2.5 and 3.5 day post coitum (d.p.c). upper panel, inverse picture of ethidium bromide stained 
agarose gel shows a typical RT-PCR reaction; lower panel, bars, means ± SEM of the densitometric analysis. B. Representative 
RT-PCR analysis of 20α-HSDc mRNA in PRLR+/+ and -/- ovaries at 0.5, 1.5, 2.5, 3.5 day post coitum (d.p.c) and at the end of 
pregnancy (D19.5) in +/+ mice as positive control.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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PRL on the corpus luteum. Our investigations have lead us
to conclude that although PRL is essential for mainte-
nance of the corpus luteum during gestation, it is not nec-
essary during folliculogenesis nor for ovulation and CL
formation.
Irregular mating patterns of half of the PRLR-/- females in-
dicating an alteration of estrous cyclicity have been previ-
ously observed [6]. We show here no alteration of the
rhythmic periodicity of the estrous cycle on a pure genetic
background of these mice suggesting that the regulatory
mechanisms of estrogen synthesis are not impaired and
that the absence of the PRL surge does not affect the length
of luteal phase [8]. In addition, the amount of oocytes re-
covered just after ovulation was not altered indicating that
PRL deficiency does not preclude the presence of FSH and
LH receptors, nor limit minor factors required for appro-
priate pituitary hormone responsiveness, providing
strong evidence for an absence of a direct role of PRL in
the mechanisms of ovulation.
Previous investigations demonstrated that PRL exhibited
dual roles, leading to DNA degradation in rat corpora
lutea at proestrus [22] while acting as an anti-apoptotic
Figure 8
Analysis of IGFBP-3 mRNA expression in wild type PRLR+/+, and PRLR-/- females. Semi quantitative RT-PCR analysis (using 
GAPDH as an internal control) of IGFBP-3 mRNA in +/+ (black bars) and -/- (hatched bars) ovaries at 0.5, 1.5, 2.5 and 3.5 day 
post coitum (d.p.c.); upper panel, inverse picture of ethidium bromide stained agarose gel shows a typical RT-PCR reaction; 
lower panel, bars, means ± SEM of the densitometric analysis.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
Page 13 of 16
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Figure 9
Analysis of cyclin D2 and p27 in ovarian tissue. Equal amounts of total protein from ovaries were resolved on 12.5% SDS-PAGE 
gels and transferred to nitrocellulose membrane then probed with antibodies described in materials and methods section. Pro-
teins were analyzed from PRLR+/+ and -/- mice at 1.5 and 2.5 d.p.c. Four mice of each genotype were analyzed. Equal amount 
of total proteins have been loaded as demonstrated by the actin signal. Upper panel, Representative Western blot; lower pane, 
bars, means ± SEM of the densitometric analysis of cyclinD2 (black bars) and p27 (hatched bars) after normalization of signals 
against actin.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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agent in functional CL [23]. Cells of PRLR-/- CL failed to
organize appropriately and underwent dramatic apopto-
sis, clearly demonstrating the anti apoptotic role of PRL in
agreement with a recent study [24]. Proliferation of en-
dothelial cells is required for the neovascularization dur-
ing luteal development which results in the corpus
luteum's extensive capillary network [25]. In the rat, [26]
it has been shown that PRL secretion, induced by mating
leads to increased endothelial cell proliferation in the CL
of pregnancy. Its survival beyond diestrus depends on PRL
stimulation and it is associated with an increase in luteal
size and vascularization. In the PRLR-/- CL, such a vascu-
larization failed to develop and thus the presence of the
PRLR appears to be crucial for the induction of vascular
factors.
The PRLR mediates LHR mRNA expression and thus plays
an essential role in progesterone production [27,28]. The
signaling mechanism by which PRL increases the LHR ex-
pression is still not known. We demonstrated that in the
complete absence of PRL signaling, LHR mRNA expres-
sion failed to increase. The changes in LH receptor mRNA
parallel those in LH binding activity during ovarian cell
differentiation, indicating that regulation of LH receptor
mRNA is a major determinant in the expression of LH re-
ceptor numbers in these cells [29].
The luteinization process involves exit of the cells from
the cell cycle, cellular hypertrophy, acquisition of ster-
oidogenic morphology, and expression of cytochrome
P450scc. It has been reported that in order for estradiol or
LH to cause cholesterol accumulation in the cycling CL,
previous exposure to lactogens is required [30] although
PRL alone can increase luteal levels of cholesterol [3]. This
is not the rate-limiting step in progesterone secretion in
vivo because HDL receptor knockout mice, which are in-
fertile, secrete normal amounts of progesterone [31]. As a
consequence of the low level of LHR expression, numer-
ous enzymes involved in steroidogenesis and known to be
under LH control such as StAR, P450scc, 3-β HSD are se-
verely reduced. Since StAR is a key of steroidogenesis [32],
the StAR deficient female exhibit a markedly decreased
level of circulating progesterone [33]. Moreover it has
been shown that the human 3β-HSD promoter is activat-
ed by PRL through the Stat 5 response element [34] dem-
onstrating that PRL has the ability to regulate expression
of a key human enzyme gene (type II 3β-HSD) in the pro-
gesterone biosynthetic pathway. The outcome of direct or
indirect controls via PRL or LH on steroidogenic enzymes
is an absence of progesterone synthesis. However, even if
progesterone biosynthesis does occur in PRLR-/- mice, it
could be rapidly metabolized to 20α-dihydroprogester-
one since in the absence of PRL signaling, we demonstrat-
ed an activation of the 20α HSD enzyme. One possible
mechanism of action of PRL in CL may be modulation of
the cell cycle. Progression through the cell cycle is orches-
trated by successive activation of cyclin-dependent kinases
which are regulated by specific cyclins as well as inhibi-
tors. The LH surge induces exit from the cell cycle not only
by elevating the levels of cell-cycle inhibitors, such as p27
and p21 but by completely down regulating the activator,
cyclin D2 [19]. Luteal cells then remain arrested in a non-
proliferative state throughout the existence of the func-
tional CL. Cdk4 has been also reported to be critical for
luteal function, and some redundant protein(s) can com-
pensate for the absence of Cdk4 in proliferation of
granulosa cells).)[35]. In the absence of PRL signaling, our
results show that luteal cells failed to express p27 at high
levels as luteinization occurs. P27 deficient females exhib-
it granulosa cell hyperplasia and a failure of luteinizing
cells to withdraw from the cell cycle and produce factors
necessary to support implantation and early pregnancy
[36]. But in these mice, the circulating level of progester-
one is maintained and it was proposed that growth arrest
was not required for the differentiation of luteal cells to a
progesterone producing state, but that it might be re-
quired to properly regulate other luteal functions. Indeed
low levels of progesterone in PRLR-/- are independent of
the proliferative state and the accumulation of corpora
undergoing regression expressing high levels of 20α HSD
would further contribute to a decrease in the levels of
progesterone.
The Stat5 proteins, major mediators of the PRL pathway,
are essential for the development of functional corpora
lutea in the ovary [37], this is consistent with the critical
role that PRL has on ovarian function also based on fe-
male infertility of PRL and PRLR deficient mice [6,38]. The
disruption of the p27 gene results in ovarian defects
similar to those observed in Stat 5-deficient mice [18]. It
is tempting to speculate that PRL regulates p27 expression
and that this expression is critical for inducing the differ-
entiation of luteal cells for the formation of functional
corpora lutea.
In situ hybridization studies have shown that IGFBP3
mRNA is highly expressed after ovulation in CL and selec-
tively localized to some cell types making this protein as a
CL functional marker [16]. We showed that IGFBP3
mRNA expression was greatly decreased in PRLR-/- mice
confirming the possible role of endothelial IGFBP-3 in
controlling angiogenesis and cell responses as described
in the human CL by autocrine/paracrine mechanisms
[39].
Recently, it has been shown that puromycin-sensitive
aminopeptidase (PSA) deficient mice are also infertile
because of impaired formation of corpus luteum due to
an absence of semicircadian surges of PRL [40]. This
mouse model again underlines the importance of PRL sig-Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/12
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naling in the maintenance of the corpus luteum. Further
analysis of these different mouse models should reveal the
molecular targets of PRL in the ovary, since the
mechanism induced by PRL which leads to luteal cell sur-
vival regulation involves intermediate molecules still to
be identified.
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